Literature DB >> 24963522

Vical initiates vaccine trials against HSV-2 and CMV.

Eva M Riedmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24963522

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  2 in total

1.  Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.

Authors:  William P Halford; Joshua Geltz; Ronald J Messer; Kim J Hasenkrug
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

Review 2.  Developments in Vaccination for Herpes Simplex Virus.

Authors:  Rohini Krishnan; Patrick M Stuart
Journal:  Front Microbiol       Date:  2021-12-07       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.